Immunity in Cryptococcosis: an Overview

Overview

Journal Mycopathologia

Specialties Microbiology
Pharmacology

Date 1982 Mar 19

PMID 7040977

Citations 9

Authors

R A Fromtling

H J Shadomy

Affiliations

Soon will be listed here.

Abstract

Cryptococcosis is an often fatal opportunistic fungal infection. Despite efforts to elucidate the role of immunity in host defense against the disease, much remains to be learned. The purpose of this brief review is to provide the reader with an overview of the history of research concerned with host immunity in cryptococcosis. both humoral and cell-mediated studies are included. An effort has been made to present the reader with a comprehensive list of references in the hope of encouraging additional reading and research in this important area.

Citing Articles

Methods of Cryptococcal Polysaccharide Analysis Using ELISA.

Wear M, McConnell S, Greengo S, Lopes L, Casadevall A Methods Mol Biol. 2024; 2775:239-255.

PMID: 38758322 DOI: 10.1007/978-1-0716-3722-7_16.

Olfactory mucosa response in guinea pigs following intranasal instillation with Cryptococcus neoformans. A histological and immunocytochemical study.

Lima C, Vital J Mycopathologia. 1994; 126(2):65-73.

PMID: 8065433 DOI: 10.1007/BF01146198.

Cryptococcus neoformans: in vivo protection of mice by pretreatment with pyran copolymer.

Fromtling R, Shadomy H, Kaplan A Mycopathologia. 1984; 85(1-2):3-7.

PMID: 6374462 DOI: 10.1007/BF00436694.

Effect of cyclophosphamide on rats experimentally infected with Cryptococcus neoformans.

Riera C, Masih D, Rubinstein H, Nobile R, Vega V Mycopathologia. 1984; 88(2-3):127-30.

PMID: 6335569 DOI: 10.1007/BF00436442.

Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.

Granger D, Perfect J, Durack D J Clin Invest. 1985; 76(2):508-16.

PMID: 3928681 PMC: 423853. DOI: 10.1172/JCI112000.

References

Tacker J, Farhi F, Bulmer G . Intracellular fate of Cryptococcus neoformans. Infect Immun. 1972; 6(2):162-7. PMC: 422509. DOI: 10.1128/iai.6.2.162-167.1972. View

Murphy J, COZAD G . Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun. 1972; 5(6):896-901. PMC: 422459. DOI: 10.1128/iai.5.6.896-901.1972. View

GADEBUSCH H . Active immunization against Cryptococcus neoformans. J Infect Dis. 1958; 102(3):219-26. DOI: 10.1093/infdis/102.3.219. View

Shahar A, Aronson M . Formation of histiocyte rings in response to Cryptococcus neoformans infection. J Reticuloendothel Soc. 1965; 2(3):249-55. View

Louria D . Specific and non-specific immunity in experimental cryptococcosis in mice. J Exp Med. 1960; 111:643-65. PMC: 2137279. DOI: 10.1084/jem.111.5.643. View

BERGMAN F, STORMBY K . A study of white blood cell and antibody response in mice infected subcutaneously with Cryptococcus neoformans. Sabouraudia. 1965; 4(2):106-11. DOI: 10.1080/00362176685190261. View

DIAMOND R . Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis. Infect Immun. 1977; 17(1):187-94. PMC: 421100. DOI: 10.1128/iai.17.1.187-194.1977. View

Kozel T, Cazin J . Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide. Infect Immun. 1971; 3(2):287-94. PMC: 416145. DOI: 10.1128/iai.3.2.287-294.1971. View

Bulmer G, Sans M . Cryptococcus neoformans. II. Phagocytosis by human leukocytes. J Bacteriol. 1967; 94(5):1480-3. PMC: 276851. DOI: 10.1128/jb.94.5.1480-1483.1967. View

10.

Powell K, Dahl B, Weeks R, TOSH F . Airborne Cryptococcus neoformans: particles from pigeon excreta compatible with alveolar deposition. J Infect Dis. 1972; 125(4):412-5. DOI: 10.1093/infdis/125.4.412. View

11.

Kligman A . Studies of the capsular substance of Torula histolytica and the immunologic properties of Torula cells. J Immunol. 2010; 57(4):395-401. View

12.

Reiss F, Szilagyi G, Mayer E . Immunological studies of the anticryptococcal factor of normal human serum. Mycopathologia. 1975; 55(3):175-8. DOI: 10.1007/BF00491504. View

13.

Louria D, Kaminski T, Finkel G . FURTHER STUDIES ON IMMUNITY IN EXPERIMENTAL CRYPTOCOCCOSIS. J Exp Med. 2009; 117(3):509-20. PMC: 2180444. DOI: 10.1084/jem.117.3.509. View

14.

Fromtling R, Shadomy H, Jacobson E . Decreased virulence in stable, acapsular mutants of cryptococcus neoformans. Mycopathologia. 1982; 79(1):23-9. DOI: 10.1007/BF00636177. View

15.

Hay R, Reiss E . Delayed-type hypersensitivity responses in infected mice elicited by cytoplasmic fractions of Cryptococcus neoformans. Infect Immun. 1978; 22(1):72-9. PMC: 422118. DOI: 10.1128/iai.22.1.72-79.1978. View

16.

Bennett J, Hasenclever H . CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION. J Immunol. 1965; 94:916-20. View

17.

BAUM G, Artis D . CHARACTERIZATION OF THE GROWTH INHIBITION FACTOR FOR CRYPTOCOCCUS NEOFORMANS (GIFC) IN HUMAN SERUM. Am J Med Sci. 1963; 246:53-7. DOI: 10.1097/00000441-196307000-00007. View

18.

Kozel T, McGaw T . Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages. Infect Immun. 1979; 25(1):255-61. PMC: 414445. DOI: 10.1128/iai.25.1.255-261.1979. View

19.

DIAMOND R, Root R, Bennett J . Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J Infect Dis. 1972; 125(4):367-76. DOI: 10.1093/infdis/125.4.367. View

20.

Louria D, Kaminski T . Passively-acquired immunity in experimental cryptococcosis. Sabouraudia. 1965; 4(2):80-4. DOI: 10.1080/00362176685190211. View